Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 248 across all filing types
Latest filing 2025-06-25 Director's Dealing
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share acquisition (장내매수) by an executive (임기섭) of Myungmoon Pharm Co., Ltd. This is a standard regulatory filing in South Korea for reporting insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2025-06-25 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Myungmoon Pharm Co., Ltd. for the period ending March 31, 2025. It contains detailed financial statements, business operations, and management analysis, which is characteristic of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director/auditor appointments, and board compensation limits. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2025-03-26 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a '사업보고서' (Business Report) for Myungmoon Pharm Co., Ltd. for the fiscal year 2024 (ending Dec 31, 2024). It contains detailed financial data, business operations, management information, and governance details, which are characteristic of an Annual Report (10-K equivalent in the Korean market). The document is clearly the full report itself, not an announcement or a summary. FY 2024
2025-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Myungmoon Pharm. It provides the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and details regarding the external auditor. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and submission of the audit report to the exchange, rather than the full annual report document itself. Therefore, it is classified as an Audit Report/Information filing. FY 2024
2025-03-18 Korean
사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is titled '사업보고서' (Business Report) for Myungmoon Pharm Co., Ltd., covering the fiscal year from January 1, 2024, to December 31, 2025. It contains comprehensive financial data, management discussion, business overview, and operational details, which are characteristic of an Annual Report (10-K equivalent in the Korean regulatory context). FY 2024
2025-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.